This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Setipiprant
Selective DP2 (prostaglandin D2 receptor) antagonist.
Aliases (3)
Overview
What is Setipiprant?
Selective DP2 (prostaglandin D2 receptor) antagonist. Repurposed for MPB after the Garza 2012 PGD2-hair-loss mechanism paper. Kythera Phase 2 didn't read out clearly enough to advance. Research-chem supply, not currently a competitive choice vs minoxidil + topical fin.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.